Performance
Ipamorelin
Selective growth-hormone secretagogue peptide.
Bioscience
PRF-IPA
2 mg
≥ 99.5% purity
Sterile lyophilized
Research Grade
For research purposes only
LOT
VT-240512-105
- MFG
- 05/2024
- EXP
- 05/2026
- STORE
- 2–8°C
01 — Overview
Overview
A selective pentapeptide secretagogue investigated for its targeted growth-hormone release profile with minimal cross-signaling. Every VITRA batch is synthesized under ISO-class cleanroom conditions and released only after full analytical confirmation.
02 — Science
Mechanism of Action
Ipamorelin is investigated in research models for its signaling activity across the pathways relevant to growth hormone support. Interactions are studied strictly at the cellular and in-vitro level.
03 — Research
Potential Research Applications
- Secretagogue research
- Endocrine assays
- In-vitro studies
04 — Data
Technical Specifications
05 — Handling
Storage & Handling
Store lyophilized peptide at 2–8°C for short-term handling and at -20°C for long-term storage, protected from light and moisture. Avoid repeated freeze-thaw cycles.
06 — Preparation
Reconstitution Information
Reconstitute with bacteriostatic or sterile water for research use. Add diluent slowly against the vial wall and swirl gently until dissolved. Do not use if the solution appears cloudy.
07 — Verification
Certificate of Analysis
Each batch ships with a third-party certificate of analysis confirming identity, purity, and composition by HPLC and mass spectrometry. Download the COA for batch VT-240512-105 or verify authenticity against our secure batch registry.
08 — Literature
Research References
- [01]Analytical certificate of analysis available on request.
Safety Disclaimer
For research use only. Not intended for human consumption, diagnosis, treatment or prevention of any disease. This product is to be handled exclusively by qualified professionals in an appropriate laboratory setting.